Biom Pharmaceutical
PrivateCompany Overview
Biom Pharmaceutical is a biotechnology company that develops microbiome-based nutritional supplements and therapeutic modalities for various diseases and age-related conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biom Pharmaceutical Comparables
Compare Biom Pharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Notitia Biotechnologies | 83% | |
| OptiBiotix Health Plc | 77% | |
| Solarea Bio | 75% |
Biom Pharmaceutical Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 42% MoM.
- Nov 11, 2025
Monthly visitors increased 40% MoM.
Biom Pharmaceutical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biom Pharmaceutical's valuation, stock price, and market status.
Is Biom Pharmaceutical a public or private company?
Biom Pharmaceutical is a private company.
What is the current stock price of Biom Pharmaceutical?
Biom Pharmaceutical is a private company with no public stock price. Caplight tracks Biom Pharmaceutical's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Biom Pharmaceutical worth (valuation)?
Valuation information for Biom Pharmaceutical is not publicly available.
Can I buy Biom Pharmaceutical stock?
Biom Pharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biom Pharmaceutical's last funding round?
Funding round information for Biom Pharmaceutical is not publicly available.
Who are the main investors in Biom Pharmaceutical?
Investor information for Biom Pharmaceutical is not publicly disclosed.
Will Biom Pharmaceutical IPO soon?
No public IPO plans have been announced for Biom Pharmaceutical.
How can I track Biom Pharmaceutical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biom Pharmaceutical's secondary market activity and sign up for updates.